Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (2.848)

141

An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time

enthalten in: Cell reports. Medicine | 2023

von Lee, C. | Cheng, W. | Lin, P. | +6

142

Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins

enthalten in: Cell reports. Medicine | 2023

von McGrail, D. | Li, Y. | Smith, R. | +11

143

Ethanol- and PARP-Mediated Regulation of Ribosome-Associated Long Non-Coding RNA (lncRNA) in Pyramidal Neurons

enthalten in: Non-coding RNA | 2023

von Rizavi, H. | Gavin, H. | Krishnan, H. | +2

144

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer : A systematic review and meta-analysis of clinical trials

enthalten in: Cancer treatment reviews | 2023

von Iannantuono, G. | Chandran, E. | Floudas, C. | +5

145

The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells

enthalten in: Biomedicines | 2023

von Softah, A. | Alotaibi, M. | Alhoshani, A. | +11

146

Adjuvant olaparib - High risk early breast cancer with BRCA1 or BRCA2 germline mutation

enthalten in: Bulletin du cancer | 2023

von Bonneau, M. | Bellesoeur, A.

147

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Catalano, M. | Lapucci, A. | Nobili, S. | +7

148

SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure : BOP)

enthalten in: Virchows Archiv : an international journal of pathology | 2023

von Cimadamore, A. | Rescigno, P. | Conteduca, V. | +8

149

Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages

enthalten in: Cell reports | 2023

von Kim, H. | Aliar, K. | Tharmapalan, P. | +23

ErratumIn: Cell Rep. 2023 Oct 25;42(11):113382. - PMID 37883228

150

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma

enthalten in: Cell reports | 2023

von Xu, Y. | Spear, S. | Ma, Y. | +9